November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Ishwaria Subbiah: Honored to be a part of the inaugural Women Thought Leaders in Oncology hosted by TOPS
Mar 12, 2024, 15:20

Ishwaria Subbiah: Honored to be a part of the inaugural Women Thought Leaders in Oncology hosted by TOPS

Ishwaria Subbiah

“What a day! Honored to be a part of the inaugural Women Thought Leaders in Oncology hosted by TOPS, our oncology state society.
🔸Invaluable insights on progress through partnerships from National Cancer Institute (NCI) Director Kimryn Rathmell, Ronit Elk, Ph.D., Jill Gilbert, Richard Martin and so many leaders committed to cancer care in our city, state, and country.
🔸Enjoyed sharing how our teams at Sarah Cannon Research Institute and The US Oncology Network drive our systems-level commitment to clinical trials access, cancer care equity and Clinician Wellbeing
🔸Incredibly grateful to Dr. Martin for unifying us all in our shared commitment to every person with cancer!”

Ishwaria Subbiah: Honored to be a part of the inaugural Women Thought Leaders in Oncology hosted by TOPS

Ishwaria Subbiah: Honored to be a part of the inaugural Women Thought Leaders in Oncology hosted by TOPS

Source: Ishwaria Subbiah/LinkedIn

Ishwaria Subbiah is the Executive Director for Cancer Care Equity and Professional Wellness at Sarah Cannon Research Institute (SCRI). In this role, Dr. Subbiah focuses on reducing cancer outcomes disparities and diversifying clinical trial participation within SCRI’s combined research network of over more than 1,300 physicians at over 250 locations in 24 states across the US. Dr. Subbiah is a globally recognized expert in geriatric oncology, symptom management, palliative care, and healthcare professional well-being. She previously was an associate professor in the Division of Cancer Medicine at the University of Texas MD Anderson Cancer Center. She is the Chair for the ASCO Women in Oncology working group and the ASCO State of Cancer Care in America initiative.